(Q35009763)

5 August 2017

1 reference

title

Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's disease (English)

1 reference

5 August 2017

0 references

0 references

1

David M Holtzman

1 reference

5 August 2017

Kelly R Bales

2

1 reference

5 August 2017

Steven M Paul

series ordinal

3

1 reference

5 August 2017

Ronald B DeMattos

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Advanced Drug Delivery Reviews

5 August 2017

published in

1 reference

5 August 2017

volume

54

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1603-1613

1 reference

Alzheimer's disease: genotypes, phenotypes, and treatments

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Genetic neurodegenerative diseases: the human illness and transgenic models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Structural neurology: are seeds at the root of neuronal degeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Erratum: correction: Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Abeta immunization: moving Abeta peptide from brain to blood

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900158-8

7 January 2021

10.1016/S0169-409X(02)00158-8

Identifiers

DOI

1 reference

5 August 2017

1 reference